Ideaya Biosciences Valuation
| IDYA Stock | USD 26.60 1.06 4.15% |
At this time, the firm appears to be overvalued. Ideaya Biosciences retains a regular Real Value of $24.83 per share. The prevalent price of the firm is $26.6. Our model calculates the value of Ideaya Biosciences from evaluating the firm fundamentals such as Return On Equity of -0.21, return on asset of -0.16, and Shares Outstanding of 86.43 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Ideaya Biosciences' valuation include:
Price Book 1.8701 | Enterprise Value 1.3 B | Enterprise Value Ebitda (7.80) | Price Sales 586.2024 | Forward PE 4.649 |
Overvalued
Today
Please note that Ideaya Biosciences' price fluctuation is not too volatile at this time. Calculation of the real value of Ideaya Biosciences is based on 3 months time horizon. Increasing Ideaya Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ideaya Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ideaya Stock. However, Ideaya Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.6 | Real 24.83 | Target 36.08 | Hype 26.6 | Naive 24.46 |
The real value of Ideaya Stock, also known as its intrinsic value, is the underlying worth of Ideaya Biosciences Company, which is reflected in its stock price. It is based on Ideaya Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ideaya Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ideaya Biosciences helps investors to forecast how Ideaya stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ideaya Biosciences more accurately as focusing exclusively on Ideaya Biosciences' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Ideaya Biosciences' intrinsic value based on its ongoing forecasts of Ideaya Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Ideaya Biosciences' closest peers. If more than one evaluation category is relevant for Ideaya Biosciences we suggest using both methods to arrive at a better estimate.
Ideaya Biosciences Cash |
|
Ideaya Valuation Trend
Comparing Ideaya Biosciences' enterprise value against its market capitalization is a good way to estimate the value of Ideaya Biosciences uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Ideaya Biosciences Total Value Analysis
Ideaya Biosciences is currently anticipated to have valuation of 1.31 B with market capitalization of 2.3 B, debt of 2.87 M, and cash on hands of 268.62 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Ideaya Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.31 B | 2.3 B | 2.87 M | 268.62 M |
Ideaya Biosciences Investor Information
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ideaya Biosciences recorded a loss per share of 2.33. The entity had not issued any dividends in recent years. Based on the key indicators related to Ideaya Biosciences' liquidity, profitability, solvency, and operating efficiency, Ideaya Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Ideaya Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Ideaya Biosciences has an asset utilization ratio of 3.6 percent. This suggests that the Company is making $0.036 for each dollar of assets. An increasing asset utilization means that Ideaya Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Ideaya Biosciences Ownership Allocation
The majority of Ideaya Biosciences outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Ideaya Biosciences to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Ideaya Biosciences. Please pay attention to any change in the institutional holdings of Ideaya Biosciences as this could imply that something significant has changed or is about to change at the company.Ideaya Biosciences Profitability Analysis
The company reported the previous year's revenue of 23.39 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (38.6 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Ideaya Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Ideaya Biosciences and how it compares across the competition.
About Ideaya Biosciences Valuation
The stock valuation mechanism determines Ideaya Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Ideaya Biosciences. We calculate exposure to Ideaya Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Ideaya Biosciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -106.1 M | -100.8 M | |
| Pretax Profit Margin | (4.83) | (5.07) | |
| Operating Profit Margin | (5.75) | (6.04) | |
| Net Loss | (4.83) | (5.07) | |
| Gross Profit Margin | (4.54) | (4.31) |
Ideaya Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 57.5 M | |
| Forward Price Earnings | 4.649 |
Ideaya Biosciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Ideaya Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Ideaya we look at many different elements of the entity such as Ideaya's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Ideaya Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Ideaya Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Ideaya Biosciences' worth.Complementary Tools for Ideaya Stock analysis
When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |